Therapeutic Proteins clinical trials at UCSF
1 research study open to eligible people
Therapeutic proteins are being tested at UCSF to treat asthma. The trial is an observational study with 120 participants at the outpatient faculty practice. If you have asthma, you may qualify to participate.
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
open to eligible people ages 18-80
This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50 asthmatics who are newly prescribed therapeutic proteins for their asthma, and 50 asthmatics already being treated with therapeutic proteins for their asthma. Participants will be seen at 1 to 3 visits and provide blood samples at each visit.
San Francisco, California
Our lead scientists for Therapeutic Proteins research studies include John V Fahy, MD.